
High-performance liquid chromatography (HPLC) confirms safe blood levels of slow-release bupivacaine nanoparticles.
ZipChip-MS streamlines mAb charge variant characterization, eliminating the need for method development. Data is seamlessly processed in Byos. This note outlines an expeditious workflow for biosimilarity assessment among mAbs.





